Glenmark Generics Inc., USA
Glenmark Generics Inc., USA appears in FDA public data with 6 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1229-2014, Class II) was initiated on March 18, 2014.
Summary
- Total Recalls
- 6
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1229-2014 | Class II | Ranitidine Tablets USP, 150 mg, 500-count bottles, Rx only, Manufactured by: Shasun Pharmaceuticals | March 18, 2014 |
| D-330-2013 | Class III | Glenmark Pravastatin Sodium Tablets ,40 mg, 90-count bottle (NDC 68462-197-90), Rx only, Manufacture | April 5, 2013 |
| D-329-2013 | Class III | Glenmark Gabapentin Tablets, a) 600mg, 500- count bottle (NDC 68462-126-05), b) 800 mg, 500- count | April 5, 2013 |
| D-331-2013 | Class III | Glenmark Topiramate Tablets, 200 mg, 60-count bottle, (NDC 68462-110-60), Rx only, Manufactured by | April 5, 2013 |
| D-182-2013 | Class III | Montelukast Sodium Tablets, 10 mg (base), packaged in a) 30-count tablets per bottle (NDC 68462-392- | February 13, 2013 |
| D-1701-2012 | Class II | NAPROXEN TABLETS USP, 500 mg, 100-count Tablets per bottle, Rx only, Manufactured by: Glenmark Gener | July 6, 2012 |